Archroma Secures $1 Billion Debt Extension as SK Capital’s Chemicals Portfolio Buckles
Updated
Updated · Bloomberg · May 14
Archroma Secures $1 Billion Debt Extension as SK Capital’s Chemicals Portfolio Buckles
1 articles · Updated · Bloomberg · May 14
Archroma won creditor approval to extend about $1 billion of junk loans, pulling off the deal only after multiple delays and sweeter terms.
The refinancing strain reflects a severe chemicals-industry downturn that has pushed several SK Capital-backed holdings into distress.
SK Capital — a roughly $10 billion private equity firm known for chemicals investing — is now being forced to adapt its strategy as the slump hits its portfolio.
As European chemical giants falter, which investors are now positioned to reshape the entire industry through consolidation?
Is private equity's high-leverage model failing the chemical sector, or creating a massive buying opportunity for the bold?
With specialist funds in distress, are retail investors being led into a high-risk, low-transparency private market trap?